Universitätsklinikum Leipzig Klinik und Poliklinik für Kinder- und Jugendmedizin
- Address
- Liebigstraße 22, Haus 7, 04103 Leipzig, Germany
Universitätsklinikum Leipzig - Pediatric Oncology and Nephrology
The Department of Pediatrics and Adolescent Medicine at Universitätsklinikum Leipzig is actively engaged in international collaborative research focused on advanced pediatric malignancies. The center participates in multinational clinical trials investigating innovative treatment approaches for childhood renal tumors, particularly those with metastatic disease requiring complex therapeutic interventions.
- Stage IV childhood renal tumors with pulmonary and non-pulmonary metastases
- Comparative efficacy studies of preoperative chemotherapy regimens
- Metastatic response assessment in pediatric solid tumors
Through participation in the SIOP RANDOMET 2017 trial, the clinic contributes to determining optimal preoperative treatment strategies for newly diagnosed metastatic renal tumors in children. This research evaluates different chemotherapy combinations to establish non-inferior therapeutic options that may offer improved outcomes while potentially reducing treatment-related toxicity in this vulnerable patient population.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1GPOH gGmbH1active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Universitätsklinikum Leipzig Klinik und Poliklinik für Kinder- und Jugendmedizin
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| AALL2131/EsPhALL2022, An International Pilot Study of Chemotherapy and Tyrosine Kinase Inhibitor with Blinatumomab in Patients with Newly Diagnosed Philadelphia Chromosome Positive or ABL-class Philadelphia Chromosome-Like B-cell Acute Lymphoblastic Leukemia | Universita Degli Studi Di Milano Bicocca | Phase III | Recruiting | Dec 2025 | — |
IMP list
lock Showing 1 of 14 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Carboplatin | 2 | Unknown | 2019-12-05 | 2024-11-21 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.